alanine and moxifloxacin

alanine has been researched along with moxifloxacin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Annes, W; Ayan-Oshodi, M; Chiesa, J; Hall, SD; Seger, M; Willis, BA; Zhang, W	1
Aldred, KJ; Breland, EJ; Kerns, RJ; McPherson, SA; Osheroff, N; Turnbough, CL	1

Trials

1 trial(s) available for alanine and moxifloxacin

Article	Year
QT effect of semagacestat at therapeutic and supratherapeutic doses. International journal of clinical pharmacology and therapeutics, 2012, Volume: 50, Issue:4 Topics: Administration, Oral; Adult; Aged; Alanine; Amyloid Precursor Protein Secretases; Analysis of Variance; Arrhythmias, Cardiac; Aza Compounds; Azepines; Cross-Over Studies; Electrocardiography; England; Enzyme Inhibitors; Female; Fluoroquinolones; Heart Rate; Humans; Least-Squares Analysis; Male; Middle Aged; Moxifloxacin; Quinolines; Risk Assessment; Risk Factors; Young Adult	2012

Article

Year

QT effect of semagacestat at therapeutic and supratherapeutic doses.

International journal of clinical pharmacology and therapeutics, 2012, Volume: 50, Issue:4

Topics: Administration, Oral; Adult; Aged; Alanine; Amyloid Precursor Protein Secretases; Analysis of Variance; Arrhythmias, Cardiac; Aza Compounds; Azepines; Cross-Over Studies; Electrocardiography; England; Enzyme Inhibitors; Female; Fluoroquinolones; Heart Rate; Humans; Least-Squares Analysis; Male; Middle Aged; Moxifloxacin; Quinolines; Risk Assessment; Risk Factors; Young Adult

2012

Other Studies

1 other study(ies) available for alanine and moxifloxacin

Article	Year
Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12 Topics: Alanine; Anti-Bacterial Agents; Bacillus anthracis; Cations, Divalent; Ciprofloxacin; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Manganese; Models, Molecular; Moxifloxacin; Mutation; Nickel; Protein Subunits; Recombinant Proteins; Topoisomerase Inhibitors; Valine; Water	2014

Article

Year

Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridge.

Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

Topics: Alanine; Anti-Bacterial Agents; Bacillus anthracis; Cations, Divalent; Ciprofloxacin; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Manganese; Models, Molecular; Moxifloxacin; Mutation; Nickel; Protein Subunits; Recombinant Proteins; Topoisomerase Inhibitors; Valine; Water

2014